(BFW) TomTom Enters Action Camera Market With Own ‘Bandit’ Device

TomTom Enters Action Camera Market With Own ‘Bandit’ Device
2015-04-29 13:11:45.155 GMT


By Elco van Groningen
(Bloomberg) -- TomTom to start selling its action camera
from May, co. says in statement.
* Camera equipped with built-in media server, and in-camera
motion and GPS sensors
* TomTom Bandit works with smartphone app
* NOTE: TomTom hosting product event today in Amsterdam

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Elco van Groningen in Amsterdam at +31-20-589-8517 or
vangroningen@bloomberg.net
To contact the editor responsible for this story:
Simon Thiel at +44-20-3525-2814 or
sthiel1@bloomberg.net

>>> US Gapping up

Gapping up
In reaction to disappointing earnings/guidance: GPRO +12.2%, (also agreed to acquire Kolor), HERO +12.2%, MCGC +10.7%, SNCR +7.7%, GNW +7.6%, AMED +6.9%, AMED +6.9%, HAWK +6.1%, LOGM +5.8%, AMCC +5.8%, HELE +4%, BGFV +4%, MDLZ +3.3%, SMSI +3.2%, CLDX +3.1%, KTCC +2.7%, EEFT +2.5%, CLF +2.2%, NOC +2.1%, ICON +2.1%, TPX+2%, VRSK +1.9%, IACI +1.9%, HLT +1.9%, MA +1.9%, CCUR +1.8%, ESRX +1.7%, ANTM +1.7%, TWX +1.6%, WEX +1.6%, LFUS +1.4%, GD +1.4%, SLAB +1.3%, HES +1.3%, MTSI +1.1%, CRI +1.1%, XOOM +0.9%, ACHC +0.9%, ETN +0.9%, FCAU +0.9%, TAHO +0.7%

M&A news: XPO +13.1% (to Acquire Norbert Dentressangle), MCGC +12.2% ( to be acquired by PennantPark Floating Rate Capital (PFLT) for ~$4.75 per share), HOT +8.8% (Board has determined to explore a full range of strategic and financial alternatives to increase shareholder value, and has retained Lazard to assist in the process, also reported earnings)

Other news: UNXL +8.1% (files for $75 mln mixed securities shelf offering; also files for ~4.89 mln share offering of common stock by selling stockholders ), IHG +4.9% (in symp with HOT), ARIA +3.5% (Chariman, CEO and President Harvey Berger to retire in connection with settlement agreement with Sarissa Capital), AGIO +3.3% (announces that it plans to advance into AG-881 clinical development in collaboration with its cancer metabolism partner Celgene), MHR +2.5% (clarifies that in accordance with the recent amendment and waiver to the first lien credit facility, it is required to raise, by May 29, 2015, and not by any earlier date, $65 mln of aggregate net cash proceeds)

Analyst comments: VOD +1.7% (upgraded to Buy from Hold at Berenberg), LLY +1.7% (upgraded to Buy from Neutral at Citigroup
)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance: IG -26.8%, (has submitted its second abbreviated New Drug Application of 2015 with the FDA; brings total pending ANDA submissions to 24 for the company ), INAP -18.5%, SSYS -18.1%, LL -15.6%, (also CFO Daniel Terrell will leave company and DOJ indicated it is seeking criminal charges under the Lacey Act with respect to laminate flooring allegations) GPRE -11.2%, WYNN -10.8%, (also cuts dividend), BWLD -10.2%, BLDP -9.8%, NVDQ -7.8%, OTEX -7%, RES -6.3%, AKAM -5.2%, X -4.4%, SLCA -3.6%, SAVE -3.6%, PNRA -3.3%, CRUS -3.2%, ARLP -3.1%, ULTI -3%, TWTR -2.6%, (late move lower on early earnings release), BBVA -2.3%, AFL -2.2%, AUY -2%, FARO -1.9%, WDC -1.9%,LINE -1.9%, ACGL -1.7%, FUN -1.5%, SO -1.3%, CALX -1.2%, AIZ -1%, (exploring strategic alternativces for employee benefits and health business segment; Provides Q1 Outlook), GRMN -1%, BMR -0.9%, KRFT -0.8%, PSEM -0.8%, WM -0.8%

Select metals/mining stocks trading lower: MT -3.3%, BHP -2.5%, BBL -2.2%, RIO -1.6%, FCX -1.4%

Other news: ASND -9.5% (announced results from Phase 1 study of TransCon Treprostinil, stating that injection-site tolerability issues did not meet the criteria defined in the target product profile), SVU -7.5% (Stephen Feinberg (Cerberus Capital) discloses 8.0% active stake in 13D filing; filing did not mention any plans to hold discussions with management), RES -6.3% (announces a reduction in its quarterly dividend to $0.05/share from $0.105/share), MGM -4.5% (following WYNN earnings/guidance), HASI -4.3% (announces commencement of a 4 mln share, public offering of common stock), BGS -4.1% (announces its intention to offer 4.2 mln shares of its common stock ), MPEL -4.1% (following WYNN earnings/guidance), DDD -4% (following SSYS guidance), LVS -4% (following WYNN earnings/guidance), ALQA -3.9% (announces proposed public offering of common stock), XONE -3.5% (following SSYS guidance), POST -1.5% (reported information regarding an avian influenza incident at one of its Michael Foods Group segment third party contracted egg suppliers), SO -1.3% (disclosed it will record pre-tax charge to income for the estimated probable losses on the Kemper IGCC of ~$5.6 mln after tax in Q1), LEAF -1.2% (upsizes and prices 27,864,525 shares of its common stock at a public offering price of $51.50 per share)

Analyst comments: AKS -1.9% (removed from Short-Term Buy List at Deutsche Bank), DB -1.4% (downgraded to Sell at Berenberg), GLW -1.1% (downgraded to Sell from Underperform at Credit Agricole)

>>> Twitter- Color on Qtr: Analysts Disappointed

Twitter- Color on Qtr: Analysts Disappointed

  • Stifel Research notes Twitter missed consensus revenue expectations by roughly 5% and lowered its full-year revenue outlook by 5% and adj. EBITDA guidance by 7%. Monthly active user additions were in-line with expectations largely shaped by positive commentary during 4Q earnings. However, 2Q:15 MAUs are off to a "slow start" and the inclusion of SMS-only users in MAU disclosures going forward could mask Twitter's true organic user growth. Firm is lowering price target to $36 and maintain Sell rating.
  • Oppenheimer notes it is lowering '16E EBITDA 8% & removing $46 price target on limited revenue visibility around new advertising initiatives. Higher direct-response auction floor prices drove weaker demand. As a result, 1Q revenue 4% below consensus, & mgmt lowered FY guidance 5%. Furthermore, US MAUs (+15% y/y) decelerated 200 bps & mgmt indicated 2Q user growth is slowing, which firm attributes somewhat to tougher '14 World Cup comps. DoubleClick deal should increase ad volume at lower pricing, with higher sales leverage. However, impact is hard to quantify given limited disclosure. Maintain Perform.
  • RBC Capital notes Three Quarter Keys -- 1) Significant Revenue Growth Deceleration; 2) EBITDA Outperformance -- Despite the Revenue miss, TWTR was still able to outperform on EBITDA, suggesting significant leverage in the model;; 3) MAU Results In-Line Though Outlook Commentary Unsettling; mgmt's expressly cautious commentary about Q2 MAUs raises questions about the user value proposition. Reiterates Sector Perform, lowers target to $47 from $54.
  • Brean Capital notes Twitter reported a weaker Q1'15 quarter and outlook. Although firm noted that Twitter had the most risk amongst coverage universe heading into numbers, it's longer term Buy thesis remains intact. Changes in pricing options and engagement measurements adversely impacted the quarter and guidance, but are important to the long term story: attracting larger budget branded advertisers. Continue to believe that Twitter is in the early innings of a long game—one that will not be linear. Reiterate Buy rating but have cut tgt to $55 from $61.
  • Wunderlich Securities notes TWTR reported 1Q15 revenues 4% below and adjusted EBITDA 8% above consensus estimates, with revenues affected by weaker-than-expected results from its direct response ad products and currency exchange headwinds. Without fx headwinds, the company would have posted revenue growth at the top of its guidance range and just below the consensus. Monthly active users (MAUs) were inline at 302 million, an addition of 14 million, although the company has gotten off to a slower start in April and should see slower MAU growth in Q2. Firm is lowering estimates given the guidance and also lowering price target to $40 from $50.
Shares of TWTR are down approx 19% since the 'leak' of its earnings.

>>> Goodyear Tire beats by $0.10, misses on revs

Goodyear Tire beats by $0.10, misses on revs

Reports Q1 (Mar) earnings of $0.54 per share, excluding non-recurring items, $0.10 better than the Capital IQ Consensus Estimate of $0.44; revenues fell 10.0% year/year to $4.02 bln vs the $4.09 bln consensus.
  • Company reaffirms the following guidance: Segment Operating Income growth of between 10 percent and 15 percent per year; Annual positive Free Cash Flow from Operations and, An Adjusted Debt to EBITDAP ratio of 2.0x to 2.1x.